Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongfang Han

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Aging Neuroscience|November 7, 2025
Diagnostic classification of mild cognitive impairment in Parkinson's disease using subject-level stratified machine-learning analysisJing Wang, Yanfang Chen, Xiao Xie, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trialJianzhong Zhang, Cheng Zhou, Guoying Miao, et al.
Chinese Medical Journal|March 18, 2026
Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trialLin Cai, Furen Zhang, Guoqiang Zhang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Aging Neuroscience|November 7, 2025
Diagnostic classification of mild cognitive impairment in Parkinson's disease using subject-level stratified machine-learning analysisJing Wang, Yanfang Chen, Xiao Xie, et al.
Journal of the American Academy of Dermatology|September 18, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trialJianzhong Zhang, Cheng Zhou, Guoying Miao, et al.
Chinese Medical Journal|March 18, 2026
Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trialLin Cai, Furen Zhang, Guoqiang Zhang, et al.
Pageof 2